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 Abstract 
Recent studies have correlated metabolic diseases, such as metabolic 
syndrome and non-alcoholic fatty liver disease, with the circadian clock. However, 
whether such metabolic changes per se affect the circadian clock remains 
controversial. To address this, we investigated the daily mRNA expression profiles 
of clock genes in the liver of a dietary mouse model of non-alcoholic steatohepatitis 
(NASH) using a custom-made, high-precision DNA chip. C57BL/6J mice fed an 
atherogenic diet for five weeks developed hypercholesterolemia, oxidative stress, 
and NASH. DNA chip analyses revealed that the atherogenic diet had a great 
influence on the mRNA expression of a wide range of genes linked to 
mitochondrial energy production, redox regulation, and carbohydrate and lipid 
metabolism. However, the rhythmic mRNA expression of the clock genes in the 
liver remained intact. Most of the circadianly expressed genes also showed 24-h 
rhythmicity. These findings suggest that the biological clock is protected against 
such a metabolic derangement as NASH. 
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Various behavioral and physiological processes, including feeding behavior 
and energy metabolism, exhibit circadian (i.e., 24-h) rhythmicity, which may play a 
role in maintaining functional homeostasis. Recent studies have revealed that the 
circadian clock system consists essentially of a set of clock genes [1; 2]. In 
mammals, the circadian clock resides in the hypothalamic suprachiasmatic nucleus 
(SCN), which is recognized as being the master clock, and in almost all peripheral 
tissues [3]. The SCN appears to coordinate peripheral clocks, because it is not 
essential for driving peripheral oscillations [3]. 
Rhythmic transcriptional enhancement by two basic helix–loop–helix 
transcription factors, CLOCK and brain and muscle Arnt-like protein 1 (BMAL1), 
provides the basic drive for the intracellular clock [1; 2]. In parallel, the 
heterodimer activates the transcription of various clock-controlled genes. Given 
that some clock-controlled genes also serve as transcription factors, the expression 
of numerous genes may be tied to the functions of the circadian clock [1; 2]. For 
example, nearly half of the known nuclear receptors, including peroxisome 
proliferator-activated receptors (α, γ, δ) and thyroid hormone receptors (α, β), 
exhibit circadian expression in liver and adipose tissues, providing a possible 
explanation for the cyclical behavior of carbohydrate and lipid metabolism [4]. 
Recent studies have demonstrated relationships between circadian clock 
function and the development of metabolic diseases, such as type 2 diabetes, 
metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). In mice, 
homozygous mutations in the Clock gene lead to the development of metabolic 
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 syndrome [5]. Moreover, we showed that the rhythmic expression of clock genes is 
blunted in the liver and visceral adipose tissues in KK-Ay mice, a genetic model of 
obese diabetes [6]. In humans, a similar effect in type 2 diabetes was found in 
peripheral leukocytes [7]. Furthermore, genetic variations in the BMAL1 gene are 
associated with susceptibility to type 2 diabetes and hypertension [8], and CLOCK 
haplotypes are associated with metabolic syndrome [9] and NAFLD [10]. Thus, 
impairment of the circadian clock appears to contribute to the development of 
metabolic diseases. 
However, whether metabolic diseases per se affect the circadian clock remains 
controversial. High glucose down-regulates mRNA expression of the clock genes 
(Per1 and Per2) in cultured fibroblasts [11]. Additionally, the DNA-binding 
activity of the CLOCK-BMAL1 heterodimer is regulated by the redox state, at least 
in vitro [12]. Kohsaka et al. [13] reported that a high-fat diet affected the rhythmic 
mRNA expression of Clock, Bmal1, and Per2 in the liver and adipose tissues of 
mice. Considering these findings, alterations in glucose, lipid, and energy 
metabolism; redox state; and/or the concentrations of humoral factors, such as 
plasma glucose, appear to influence the peripheral circadian clock. However, Oishi 
et al. [14] demonstrated that clock function was preserved, to a large degree, in the 
livers, hearts, and kidneys of mice with streptozotocin-induced insulinopenic 
diabetes. We also revealed that the circadian clock is hardly impaired in the liver 
and adipose tissues of non-obese, mild hyperglycemic Goto-Kakizaki rats [15]. 
Furthermore, we did not observe impairment of the circadian clock in the liver or 
adipose tissues of mice fed a high-fat diet, even though the mice developed 
metabolic syndrome, characterized by obesity, hyperlipidemia, and hyperglycemia 
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 [16]. Although the reasons for these discrepancies among the various studies are 
unknown, one reason might be differences in the severity of the pathological 
condition. 
Non-alcoholic steatohepatitis (NASH) is an aggressive form of NAFLD, and 
the liver with steatosis and inflammation develops hepatic insulin resistance, 
lipotoxicity, oxidative stress, and mitochondrial abnormalities, which lead to 
hepatic fibrosis or cirrhosis [17]. We recently established a mouse model of NASH, 
induced by feeding an atherogenic diet [18]. In this model, the atherogenic diet 
induced steatosis, inflammation, cellular ballooning, stellate cell activation, hepatic 
insulin resistance, lipid peroxidation, and oxidative stress in the liver; it finally 
caused hepatic cirrhosis. Thus, the pathological conditions in the liver of this model 
are complex and quite severe compared with those of mice fed a simple high-fat 
diet [13] [16]. Therefore, it is reasonable to expect that the hepatic circadian clock 
may be impaired in this model, if the alterations in metabolism and redox state 
affect the oscillator. To test this, we developed a custom-made, high-precision 
DNA chip useful for analyzing the metabolic status of the liver and investigated the 
rhythmic mRNA expression of clock genes and genes linked to carbohydrate and 
lipid metabolism, energy production, and redox regulation in the livers of mice fed 
an atherogenic diet. 
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 Materials and Methods 
 
Mice.  Male C57BL/6J mice (Charles River Laboratories Japan, Yokohama, 
Japan) were obtained at five weeks of age and maintained under conditions of 
controlled temperature and humidity and a 12-h light (08:45–20:45 h)/12-h dark 
(20:45–08:45 h) cycle. Mice had free access to food and drinking water. After three 
days of acclimation, the mice were divided into two groups. Half of the mice 
(n = 16) were fed a standard laboratory diet (CRF-1, Oriental Yeast Co., Tokyo, 
Japan), whereas the others (n = 16) were given an atherogenic diet (Research Diets, 
New Brunswick, NJ) containing 34.3% fat (lard, soybean oil), 25.8% protein 
(casein, L-cystine), 24.6% carbohydrate (maltodextrin, sucrose), 1.3% cholesterol, 
0.5% sodium cholate, 5.7% mineral mixture, 1.5% vitamin mixture, and 6.3% 
cellulose. After five weeks of feeding, animals were sacrificed to obtain blood and 
liver samples at the following zeitgeber times (ZT): 0, 6, 12, and 18, in which ZT 0 
is defined as lights on and ZT 12 as lights off.  
All animal procedures were preformed in accordance with the standards set 
forth in the Guidelines for the Care and Use of Laboratory Animals at the 
Takara-machi campus of Kanazawa University (Kanazawa, Japan). 
Statistical analyses.  Differences in the variables and mRNA levels between 
mice fed the atherogenic diet and control mice were evaluated using Student’s t test. 
The rhythmicity of each gene was assessed using one-way ANOVA. The values are 
presented as the means ± SEM, and P < 0.05 was deemed to indicate statistical 
significance. All calculations were performed using SPSS software (version 11 for 
Windows, SPSS Japan, Tokyo, Japan). 
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 Additional details on methods.  For details on the blood chemistry, DNA chip 








Development of a custom-made DNA chip suitable for metabolic research.  
We established a database of hepatic gene expression profiles in various human 
diseases, and rodent models of diabetes and/or obesity. The models include patients 
with type 2 diabetes, with or without obesity [19; 20; 21; 22; 23; 24] and NAFLD 
[25]; genetic rodent models of type 2 diabetes and/or obesity [6; 26]; diet-induced 
rodent models of obesity [27]; diet-induced rodent models of NAFLD [18; 28; 29]; 
and a rodent model of ischemic heart disease (manuscript submitted). We extracted 
the significantly altered genes in each metabolic pathway both in human diseases 
and animal models and selected 190 mouse genes linked to the circadian clock, 
energy production, redox regulation, ROS defense, MAPK cascade, energy and 
cholesterol metabolism, and protein degradation. Because expression of 70 of these 
genes was hardly detected in a liver sample (FirstChoice mouse liver total RNA, 
Applied Biosystems) or was determined differently from the results analyzed by 
real-time PCR, we used data for the other 120 genes for analyses in this study 
(Supplemental Table 1). The results of the 120 genes analyzed by the DNA chip 
strongly correlated with those obtained by real-time PCR (Pearson’s correlation 
coefficient r = 0.963, P < 0.0001; Supplemental Fig. 2). 
 
Mouse model of NASH induced by feeding an atherogenic diet.  As reported 
previously [18], mice fed an atherogenic diet for five weeks developed NASH, 
diagnosed based on histology (Supplemental Fig. 3). Serum concentrations of ALT 
and total cholesterol in mice fed the atherogenic diet were significantly higher than 
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 those in control mice (Table 1). The concentration of d-ROMs was also elevated, 
suggesting that oxidative stress was induced in the mice on the atherogenic diet. 
 
Global gene expression profile in the livers of mice fed an atherogenic diet.  
Consistent with the histological and biochemical findings, the DNA chip analyses 
revealed that the atherogenic diet had a wide influence on mRNA expression, 
affecting genes linked to energy production, redox regulation, ROS defense, the 
MAPK cascade, nuclear receptors, energy and cholesterol metabolism, and protein 
degradation (Supplemental Table 2). In most of the genes examined, the 
atherogenic diet decreased transcript levels. Specifically, the mRNA expression for 
35 of 47 genes linked to energy production and redox regulation, 11 of 16 energy 
metabolism-related genes, and five of six cholesterol metabolism-related genes was 
significantly suppressed at one or more time points. However, there was no 
significant difference in the hepatic mRNA expression levels of clock genes 
between the mice fed the atherogenic diet and control mice at any time point 
(Supplemental Table 2). This finding was verified by real-time quantitative PCR 
(Fig. 1). 
In control mice, the DNA chip analyses detected rhythmic mRNA expression 
in 31 genes, in addition to the clock genes (Fig. 2, Supplemental Fig. 4 and 
Supplemental Table 1). As reported previously [16], daily expression profiles of 
Cyp7a1 gene were opposite in phase between the groups (Fig. 2D). Additionally, 
the atherogenic diet dampened the mRNA expression rhythms in two of two genes 
related to ROS defense and seven of eight genes involved in protein degradation 
(Fig. 2E, Supplemental Fig. 4A and Supplemental Table 1). However, transcript 
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 levels of most of the genes related to energy production, redox regulation, MAPK 
cascade, nuclear receptors, and energy and cholesterol metabolism, as well as the 
clock genes, showed significant 24-h rhythmicity in mice fed the atherogenic diet 
and in control mice (Fig. 2A-D, Supplemental Fig. 4B and Supplemental Table 1). 
These results suggest that the circadian clock function is maintained in the livers of 
mice with NASH, probably due to compensating alterations in the expression of 




Accumulating evidence shows that the circadian clock regulates many 
physiological functions, such as carbohydrate and lipid metabolism [4], 
mitochondrial energy production, redox regulation, ROS defense [30; 31], and 
MAPK activity [32]. Thus, it is not surprising that dysfunction in the circadian 
clock can cause various disorders, including metabolic syndrome [5] and 
malignancies [33]. However, whether these pathological conditions per se cause 
impairment of clock function remains to be clarified. In particular, our previous 
finding [16] that simple fatty liver induced by high-fat feeding had little effect on 
the hepatic circadian clock in mice differs considerably from the results of Kohsaka 
et al. [13]. To address this issue, we developed a severe NASH model, with 
oxidative stress and drastic metabolic changes, and investigated the expression 
rhythms of the clock genes and metabolism- and inflammation-associated genes in 
the liver of this animal model. 
As expected, the atherogenic diet altered the mRNA expression of various 
genes related to energy production, redox regulation, the MAPK cascade, and 
carbohydrate and lipid metabolism. Additionally, these effects on mRNA 
expression exhibited daily variation; they became marked during the dark/active 
phase. Because the light condition and daily feeding profile did not differ between 
mice fed the atherogenic diet and control mice, the daily variation in the intake of 
the atherogenic diet components may have caused the difference between mRNA 
expression profiles in the dark and light phases. However, the intracellular clock 
remained intact under these drastically altered conditions. These results suggest 
 11
 that the circadian clock is protected against, or not susceptible to, alterations in the 
intracellular environment, including redox state and metabolism. 
Light and dietary intake strongly entrain the master and hepatic clocks, 
respectively [2; 31]. The master clock in the SCN may synchronize the peripheral 
oscillators, at least partly via the autonomic nervous system [2]. In this study, the 
mice with NASH were maintained on a well-regulated 12-h light/12-h dark cycle. 
Additionally, their daily feeding rhythm did not differ from that of control mice 
(data not shown). Under this condition, the hepatic clock ticked normally. Kohsaka 
et al. [13] reported that a high-fat diet lengthened the period of locomotor activity 
rhythm under constant darkness in mice, but the effect was not detected under a 
12-h light/12-h dark cycle. Moreover, night-time restricted feeding can normalize 
the impaired circadian clock in the livers of db/db mice [34]. These results suggest 
that the signals induced by light and feeding can entrain the hepatic circadian clock, 
even in the face of the alterations of metabolism and redox state. The influence of a 
high-fat diet on the hepatic clock may have been observed by Kohsaka et al. [13], 
but not us [16], due to differences in daily feeding rhythm, which was dampened in 
their study but not in ours. 
Consistent with the intact intracellular clock, the daily expression rhythms of 
most circadianly expressed genes examined were preserved in the livers of mice 
with NASH. However, the 24-h expression rhythms of some genes were blunted or 
changed by the atherogenic diet. It is interesting that the expression rhythms of 
genes involved in protein degradation were markedly changed in the mice with 
NASH. The clock proteins, as well as the other short-lived proteins, are degraded 
by the ubiquitin-proteasome system [2]. Degradation rates of the clock proteins are 
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 controlled by their phosphorylation [2] and binding to an F-box protein [35]. These 
post-translational regulation mechanisms may account for the fact that Cry2 protein 
accumulates with a markedly higher circadian amplitude than Cry2 mRNA [36]. 
Further studies are needed to determine whether the degradation rates of clock 
proteins are altered to compensate for the effects of the atherogenic diet. 
In conclusion, the atherogenic diet caused NASH and alterations in the 
intracellular environment, affecting energy metabolism, protein degradation, and 
redox state. However, these conditions did not impair the circadian clock or the 
expression rhythms of most of the genes examined in the liver. These findings 
provide evidence that the circadian clock is protected against alterations in the 
intracellular environment, including metabolism and redox state. The impairment 
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Table 1. Metabolic Parameters in Mice Fed a Regular or Atherogenic Diet 
Parameter Control Atherogenic P 
Body weight (g) 28.7 ± 0.8 23.2 ± 0.9 < 0.01 
Blood glucose (mg/dL) 166 ± 5 163 ± 8 0.73 
Serum ALT (U/L) 18 ± 1 51 ± 7 < 0.01 
Serum total cholesterol (mg/dL) 98 ± 2 151 ± 7 < 0.01 
Serum HDL-cholesterol (mg/dL) 71 ± 2 71 ± 3 0.90  
Serum triglyceride (mg/dL) 80 ± 13 14 ± 2 < 0.01 
d-ROMs (U) 20 ± 1 34 ± 3 < 0.01 
Blood samples were obtained from non-fasted mice at zeightgeber time 0 and 12 (n = 4 
for each time point in both groups). 
Data are means ± SEM of 8 mice. 
ALT, Alanine aminotransferase; HDL, high-density lipoprotein; d-ROMs, derivatives 
of reactive oxygen metabolites. 
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 Figure Legends 
 
Figure 1. 
Daily mRNA expression profiles of clock genes in the livers of mice fed a regular 
(black circles) or an atherogenic (white circles) diet. Transcript levels of the clock 
genes were determined by real-time quantitative PCR. Data are means ± SEM of 
four mice at each time point and are expressed as relative values to the lowest 
values in control mice for each gene. 
 
Figure 2.  
Daily mRNA expression profiles of the circadianly expressed genes related to the 
MAPK cascade (A), nuclear receptors (B), energy metabolism (C), cholesterol 
metabolism (D), and protein degradation (E) in the livers of mice fed a regular 
(black circles) or an atherogenic (white circles) diet. Transcript levels of the clock 
genes were determined by the custom-made, high-precision DNA chip. Data are 
means ± SEM of four mice at each time point and are expressed as relative values to 





Supplemental Table 1. Rhythmicity of Hepatic mRNA Expression in Mice Fed a Regular or Atherogenic Diet 
Control Atherogenic 
 Gene Symbol Description Accession Code F P F P 
Energy Production and Redox Regulation 
Nox4 NADPH oxidase 4 NM_015760.2 19.2 0.000 10.3 0.001  
Atp6v1e1 VATPase, H+ transporting, lysosomal V1 subunit E1 NM_007510.2 10.1 0.001 5.3 0.015  
Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 NM_021282.2 7.4 0.005 3.5 0.050  
Acox2 acyl-Coenzyme A oxidase 2, branched chain NM_053115.1 6.4 0.008 4.1 0.032  
Uqcrc2 ubiquinol cytochrome c reductase core protein 2 NM_025899.2 4.4 0.026 11.5 0.001  
Uqcr ubiquinol-cytochrome c reductase (6.4kD) subunit NM_025650.2 3.9 0.036 2.1 0.149  
Atp5c1 ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 NM_020615.2 3.6 0.046 1.9 0.185  
Atp5o ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit NM_138597.2 3.4 0.052 4.1 0.032  
Atp6v0b ATPase, H+ transporting, lysosomal V0 subunit B NM_033617.1 3.4 0.055 1.4 0.304  
Atp6v1f ATPase, H+ transporting, lysosomal V1 subunit F NM_025381.1 3.2 0.060 5.1 0.017  
Atp6v1h ATPase, H+ transporting, lysosomal V1 subunit H NM_133826.2 3.1 0.066 2.9 0.077  
Slc25a5 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 NM_007451.2 2.8 0.086 4.1 0.033  
Ndufs8 NADH dehydrogenase (ubiquinone) Fe-S protein 8 NM_144870.3 2.8 0.088 2.8 0.083  
Ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1 NM_133666.2 2.7 0.095 5.4 0.014  
Ndufs1 NADH dehydrogenase (ubiquinone) Fe-S protein 1 NM_145518.1 2.4 0.121 4.9 0.019  
Atp6v0d1 ATPase, H+ transporting, lysosomal V0 subunit D1 NM_013477.2 2.0 0.168 0.2 0.874  
Ndufa6 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14) NM_025987.1 1.9 0.185 2.1 0.149  
Ndufa7 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a) NM_023202.2 1.8 0.195 3.7 0.042  
Cox4i1 cytochrome c oxidase subunit IV isoform 1 NM_009941.2 1.8 0.196 1.2 0.364  
Cox5b cytochrome c oxidase, subunit Vb NM_009942.2 1.8 0.210 1.3 0.310  
Ndufs2 NADH dehydrogenase (ubiquinone) Fe-S protein 2 NM_153064.3 1.7 0.211 2.7 0.096  
Uqcrfs1 ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 NM_025710.1 1.6 0.234 1.7 0.212  
 
Ndufa2 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 NM_010885.2 1.6 0.244 2.3 0.124  
 
Supplemental Table 1. (continued) 
Control Atherogenic 
 Gene Symbol Description Accession Code F P F P 
Cox17 cytochrome c oxidase, subunit XVII assembly protein homolog (yeast) NM_001017429.2 1.6 0.251 0.4 0.744  
Ndufb10 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 NM_026684.1 1.5 0.268 0.3 0.857  
Ndufa3 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 NM_025348.1 1.5 0.271 2.6 0.104  
Ndufv2 NADH dehydrogenase (ubiquinone) flavoprotein 2 NM_028388.1 1.5 0.274 1.6 0.244  
Atp5a1 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 NM_007505.1 1.4 0.298 1.4 0.281  
Ndufa4 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 NM_010886.1 1.4 0.300 2.0 0.173  
Sco1 SCO cytochrome oxidase deficient homolog 1 (yeast) NM_001040026.1 1.4 0.304 17.7 0.000  
Sdha succinate dehydrogenase complex, subunit A, flavoprotein (Fp) NM_023281.1 1.3 0.307 1.3 0.313  
Atp5b ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit NM_016774.2 1.3 0.328 1.3 0.328  
Cox6a1 cytochrome c oxidase, subunit VI a, polypeptide 1 NM_007748.3 1.2 0.361 12.0 0.001  
Acox3 acyl-Coenzyme A oxidase 3, pristanoyl NM_030721.2 1.1 0.379 5.8 0.011  
Acox1 acyl-Coenzyme A oxidase 1, palmitoyl NM_015729.2 1.0 0.430 1.3 0.328  
Sdhc succinate dehydrogenase complex, subunit C, integral membrane protein NM_025321.1 1.0 0.436 2.0 0.161  
Cox5a cytochrome c oxidase, subunit Va NM_007747.2 0.9 0.470 1.4 0.290  
Uqcrb ubiquinol-cytochrome c reductase, complex III subunit VII NM_026219.1 0.9 0.484 0.9 0.449  
Atp5e ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit NM_025983.3 0.8 0.502 1.3 0.308  
Cyp4a12 cytochrome P450, family 4, subfamily a, polypeptide 12 NM_177406.3 0.8 0.515 0.8 0.539  
Atp6ap1 ATPase, H+ transporting, lysosomal accessory protein 1 NM_018794.2 0.8 0.532 1.0 0.424  
Atp6v1b2 ATPase, H+ transporting, lysosomal V1 subunit B2 NM_007509.2 0.8 0.538 6.6 0.007  
Cyp4a10 cytochrome P450, family 4, subfamily a, polypeptide 10 NM_010011.2 0.7 0.580 0.8 0.522  
Ndufb4 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 NM_026610.1 0.7 0.595 1.2 0.337  
Cox7c cytochrome c oxidase, subunit VIIc NM_007749.3 0.5 0.714 0.9 0.471  
Uqcrc1 ubiquinol-cytochrome c reductase core protein 1 NM_025407.2 0.5 0.717 1.6 0.249  
 
Atp5j ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F NM_016755.2 0.2 0.908 0.7 0.550  
 
Supplemental Table 1. (continued) 
Control Atherogenic 
 Gene Symbol Description Accession Code F P F P 
ROS Defense 
Gss glutathione synthetase NM_008180.1 5.7 0.012 3.4 0.054  
Gsr glutathione reductase 1 NM_010344.3 4.3 0.028 1.8 0.194  
Sod1 superoxide dismutase 1, soluble NM_011434.1 2.4 0.122 3.5 0.050  
Cat catalase NM_009804.1 2.1 0.157 2.3 0.129  
Txn1 thioredoxin 1 NM_011660.2 1.8 0.194 0.5 0.668  
Prdx1 peroxiredoxin 1 NM_011034.2 1.6 0.252 2.0 0.172  
Sod3 superoxide dismutase 3, extracellular NM_011435.3 1.5 0.272 3.0 0.073  
Gpx3 glutathione peroxidase 3 NM_008161.1 1.5 0.275 4.5 0.024  
Sod2 superoxide dismutase 2, mitochondrial NM_013671.3 1.3 0.305 2.6 0.099  
Gsta4 glutathione S-transferase 4 NM_010357.1 1.3 0.305 6.9 0.006  
 
Gpx1 glutathione peroxidase 1 NM_008160.2 0.8 0.542 1.6 0.240  
MAPK Cascade 
Map2k3 mitogen-activated protein kinase kinase 3 NM_008928.1 12.6 0.001 10.9 0.001  
Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NM_010907.1 10.5 0.001 9.2 0.002  
Mknk2 MAP kinase interacting serine/threonine kinase 2 NM_021462.2 7.1 0.005 3.3 0.058  
Araf v-raf murine sarcoma 3611 viral oncogene homolog NM_009703.1 3.7 0.043 20.9 0.000  
Hras1 v-Ha-ras Harvey rat sarcoma viral oncogene homolog NM_008284.1 3.1 0.068 0.7 0.567  
Mapkapk2 MAP kinase-activated protein kinase 2 NM_008551.1 2.5 0.112 0.3 0.826  
Cebpa CCAAT/enhancer binding protein (C/EBP), alpha NM_007678.2 1.3 0.311 2.3 0.129  
Map2k5 mitogen-activated protein kinase kinase 5 NM_011840.2 1.2 0.369 9.1 0.002  
Jun v-jun sarcoma virus 17 oncogene homolog (avian) NM_010591.1 0.9 0.479 3.9 0.037  
Map3k3 mitogen-activated protein kinase kinase kinase 3 NM_011947.1 0.6 0.616 3.4 0.052  
 
Grb2 growth factor receptor-bound protein 2 NM_008163.3 0.1 0.981 1.4 0.293  
 
Supplemental Table 1. (continued) 
Control Atherogenic 
 Gene Symbol Description Accession Code F P F P 
Clock Genes 
Arntl brain and muscle Arnt-like protein 1 (BMAL1) NM_007489.3 90.7 0.000 61.0 0.000  
Clock clock NM_007715.5 37.1 0.000 18.0 0.000  
Cry1 cryptochrome 1 NM_007771.3 23.2 0.000 38.3 0.000  
Per1 period 1 NM_011065.2 11.4 0.001 10.7 0.001  
Per2 period 2 NM_011066.1 8.2 0.003 40.1 0.000  
 
Cry2 cryptochrome 2 NM_009963.3 5.3 0.015 4.4 0.027  
Nuclear Receptors 
Ppard peroxisome proliferator activator receptor delta NM_011145.3 25.8 0.000 49.3 0.000  
Ppara peroxisome proliferator activated receptor alpha NM_011144.2 8.3 0.003 5.6 0.012  
Nr1i2 nuclear receptor subfamily 1, group I, member 2 (PXR) NM_010936.1 3.6 0.047 5.5 0.013  
Srebf1 sterol regulatory element binding factor 1 NM_011480.1 2.9 0.082 3.8 0.039  
Nr1h4 nuclear receptor subfamily 1, group H, member 4 (FXR) NM_009108.1 2.1 0.150 2.5 0.111  
Nr0b2 nuclear receptor subfamily 0, group B, member 2 (SHP) NM_011850.2 2.1 0.159 2.5 0.107  
Pparg peroxisome proliferator activated receptor gamma NM_011146.1 1.7 0.224 3.3 0.056  
 
Nr1h3 nuclear receptor subfamily 1, group H, member 3 (LXRa) NM_013839.2 1.2 0.356 2.6 0.100  
Energy Metabolism 
Cpt1a carnitine palmitoyltransferase 1a, liver NM_013495.1 14.0 0.000 4.7 0.022  
Gck glucokinase NM_010292.4 11.0 0.001 5.5 0.013  
Pck1 phosphoenolpyruvate carboxykinase 1 NM_011044.2 7.4 0.005 5.7 0.012  
Dgat2 diacylglycerol O-acyltransferase 2 NM_026384.3 4.9 0.019 6.5 0.007  
G6pc glucose 6-phosphatase NM_008061.3 3.1 0.068 2.1 0.160  
Pklr pyruvate kinase NM_013631.1 3.0 0.073 1.9 0.182  
 
Scd1 stearoyl-Coenzyme A desaturase 1 NM_009127.3 2.6 0.102 2.4 0.117  
 
Supplemental Table 1. (continued) 
Control Atherogenic 
 Gene Symbol Description Accession Code F P F P 
Fasn fatty acid synthase NM_007988.3 2.3 0.127 4.0 0.035  
Dgat1 diacylglycerol O-acyltransferase 1 NM_010046.2 2.0 0.162 4.3 0.027  
Pfkl phosphofructokinase NM_008826.2 1.6 0.247 3.0 0.072  
Gpd1 glycerol-3-phosphate dehydrogenase NM_010271.2 1.4 0.303 5.1 0.017  
Cpt2 carnitine palmitoyltransferase 2 NM_009949.1 1.3 0.317 1.1 0.387  
Acads acyl-Coenzyme A dehydrogenase, short chain NM_007383.2 1.2 0.338 7.3 0.005  
Acaca Acetyl-Coenzyme A carboxylase alpha NM_133360.1 0.9 0.484 1.1 0.392  
Hadha Hydroxyacyl-CoA dehydrogenase, alpha subunit NM_178878.1 0.9 0.492 1.3 0.314  
 
Acadm acyl-Coenzyme A dehydrogenase, medium chain NM_007382.1 0.8 0.501 2.8 0.083  
Cholesterol Metabolism 
Abcc2 ATP-binding cassette, sub-family C, member 2 (MRP2) NM_013806.2 11.3 0.001 8.4 0.003  
Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 NM_145942.2 9.2 0.002 6.0 0.010  
Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 NM_007824.2 4.9 0.019 4.1 0.031  
Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase NM_008255.1 3.3 0.057 5.3 0.015  
Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 NM_024264.3 2.2 0.142 2.5 0.107  
 
Ldlr low density lipoprotein receptor NM_010700.2 1.1 0.380 0.7 0.579  
Protein Degradation 
Psma5 proteasome subunit, alpha type 5 NM_011967.2 11.4 0.001 0.9 0.477  
Psma1 proteasome subunit, alpha type 1 NM_011965.1 11.0 0.001 1.0 0.431  
Ubc ubiquitin NM_019639.3 7.2 0.005 2.7 0.095  
Psmb2 proteasome subunit, beta type 2 NM_011970.2 6.8 0.006 9.5 0.002  
Psmd1 proteasome 26S subunit, non-ATPase, 1 NM_027357.1 4.2 0.030 1.0 0.428  
Psma3 proteasome subunit, alpha type 3 NM_011184.2 3.9 0.038 3.1 0.065  
 
Psmb1 proteasome subunit, beta type 1 NM_011185.2 3.8 0.039 0.2 0.925  
 
Supplemental Table 1. (continued) 
Control Atherogenic 
 Gene Symbol Description Accession Code F P F P 
Psme1 proteasome 28 subunit, alpha NM_011189.1 3.8 0.040 0.4 0.781  
Tnfsf5ip1 Proteasome assembling protein 2 (PAC2) NM_134138.1 3.0 0.073 4.2 0.030  
Psme2 proteasome 28 subunit, beta NM_011190.3 1.9 0.184 0.7 0.565  
Psmd2 proteasome 26S subunit, non-ATPase, 2 NM_134101.1 1.9 0.187 3.2 0.062  
Psmb5 proteasome subunit, beta type 5 NM_011186.1 1.7 0.217 3.8 0.039  
Psmd14 proteasome 26S subunit, non-ATPase, 14 NM_021526.1 1.0 0.406 2.0 0.165  
Dscr2 proteasome assembling protein 1 (PAC1) NM_019537.1 0.3 0.806 2.1 0.148  
 
Psme3 proteaseome 28 subunit, 3 NM_011192.3 0.1 0.950 0.3 0.795  
Liver samples were obtained from mice at ZT 0, 6, 12, and 18 (n = 4 for each time point in both groups). 
The rhythmicity of each gene was tested using one-way ANOVA. 
 
 
Supplemental Table 2. Effects of the Atherogenic Diet on Hepatic mRNA Expression 
 Gene ZT0 ZT6 ZT12 ZT18 Gene ZT0 ZT6 ZT12 ZT18
Energy Production and Redox Regulation 
Cyp4a12 0.22**  0.28**  0.17** 0.30** Ndufa2 0.87** 0.88  0.82*  0.79* 
Acox1 0.57**  0.54**  0.47** 0.56* Atp6v0d1 0.89* 0.88  0.82**  0.92 
Sdha 0.72**  0.74**  0.71* 0.75* Ndufa4 0.86* 0.89  0.85  0.80* 
Ndufb10 0.72**  0.78**  0.74* 0.73* Slc25a5 0.79** 0.92  0.95  0.84 
Uqcrc1 0.73**  0.75**  0.79* 0.70* Uqcrb 0.83** 0.86  0.84  0.80 
Ndufs1 0.74**  0.81**  0.79* 0.69* Atp5c1 0.83** 0.93  0.86  0.85 
Uqcr 0.74**  0.79**  0.71** 0.68** Ndufb4 0.85* 0.87  0.96  0.85 
Ndufv1 0.75**  0.79**  0.65** 0.65** Ndufa7 0.87 0.92  0.80*  0.80** 
Ndufs2 0.75**  0.79**  0.77* 0.71** Sco1 0.92 0.96  0.81**  0.68** 
Sdhc 0.77**  0.78**  0.78* 0.71** Atp5j 0.91 0.86  0.91  0.82* 
Atp5b 0.77**  0.83*  0.79* 0.75* Acox3 0.98 0.89  0.92  0.72* 
Atp5a1 0.77**  0.82*  0.79* 0.78* Cyp4a10 0.63 0.44  0.38  0.45 
Ndufa6 0.79**  0.87*  0.79* 0.73* Atp6v1h 0.88 1.07  1.09  0.98 
Cox6a1 0.79**  0.81**  0.62** 0.63** Cox5a 0.89 0.94  0.97  0.93 
Cox5b 0.80**  0.81**  0.72** 0.77* Cox17 0.95 0.95  0.98  1.03 
Uqcrc2 0.80**  0.76**  0.72** 0.71** Cyp2e1 0.98 0.99  0.99  1.04 
Cox4i1 0.81**  0.87*  0.79* 0.78* Acox2 1.00 0.94  1.08  0.91 
Cox7c 0.82*  0.85**  0.83* 0.78* Atp6v0b 1.01 1.06  0.87  0.89 
Uqcrfs1 0.79**  0.83*  0.84* 0.80 Atp6v1e1 1.13 1.21†  1.08  1.17† 
Atp5o 0.80**  0.84**  0.82 0.75* Atp6v1f 1.16†† 1.11  1.04  1.07 
Atp5e 0.86*  0.85*  0.91 0.80* Atp6ap1 1.18†† 1.15  1.19  1.18 
Ndufs8 0.86*  0.90*  0.89 0.78* Nox4 1.48†† 1.29††  1.14  1.19 
Ndufv2 0.75**  0.85*  0.85 0.85 Atp6v1b2 1.51† 1.44††  1.29††  1.26 
 
Ndufa3 0.86**  0.90  0.85* 0.78* 
ROS Defense 
Sod1 0.72**  0.73**  0.63** 0.64** Gpx3 1.14 0.99  1.12  0.99 
Cat 0.73**  0.70**  0.64* 0.70* Gsta4 1.19 1.14  1.18  1.14 
Sod2 0.73**  0.76**  0.81* 0.81 Gss 1.22 1.03  0.81  0.99 
Prdx1 1.00  0.93  0.83* 0.88 Txn1 1.34†† 1.13  1.19  1.32 
Gsr 1.04  0.90  0.88 0.97 Sod3 1.93†† 1.49  1.47  1.48 
 
Gpx1 1.12  1.05  0.96 1.05 
MAPK Cascade 
Cebpa 0.67*  0.74**  0.65** 0.59** Map2k5 1.20 1.27  1.08  1.00 
Araf 0.77**  0.82*  0.69* 0.60** Map3k3 1.33 1.32†  1.42†  1.14 
Hras1 0.97  1.03  0.82 0.71* Nfkbia 1.48† 1.23  1.50†  1.41 
Map2k3 1.01  1.17  0.90 0.70** Grb2 1.46†† 1.49†  1.33††  1.27 
Mknk2 1.03  1.10  0.78 0.63* Mapkapk2 1.22† 1.32††  1.49††  1.53† 
 
Jun 1.00  1.01  1.42 0.83 
 
 
Supplemental Table 2. (continued) 
 Gene ZT0 ZT6 ZT12 ZT18 Gene ZT0 ZT6 ZT12 ZT18
Clock Genes 
Clock 1.08  1.01  1.10 0.94 Cry2 1.10 1.17  1.05  0.96 
Arntl 1.05  0.84  0.93 1.03 Per1 1.22 1.57  1.11  0.95 
 
Cry1 1.04  0.92  1.15 0.99 Per2 0.83 1.10  1.02  0.92 
Nuclear Receptors 
Pparg 0.57  0.55  0.35** 0.26* Nr1h3 1.01 1.03  1.02  0.91 
Nr1h4 0.66**  0.84  0.80** 0.65* Ppara 1.21 1.01  0.84  0.84 
Nr1i2 0.86  0.78*  0.90 0.79 Srebf1 1.47 1.99††  1.34  1.25 
 
Ppard 0.85  1.13  1.10 0.95 Nr0b2 1.66† 1.23  1.02  1.72 
Energy Metabolism 
Fasn 0.27*  0.40*  0.42* 0.38** Cpt2 0.79** 0.82  0.82  0.81 
Gpd1 0.44**  0.50**  0.36** 0.40** Pfkl 0.94 0.99  0.93  0.78* 
Gck 0.46**  1.16  0.68 0.51** Acaca 0.73 0.85  0.75  0.56** 
Hadha 0.74**  0.75*  0.65** 0.65* Acadm 0.82 0.84  0.89  0.79 
Acads 0.75**  0.80*  0.68** 0.63* Dgat1 0.93 0.89  0.82  0.78 
Dgat2 0.76**  0.87*  0.79 0.60** G6pc 1.10 0.73  0.85  1.62 
Pklr 0.51**  0.65*  0.68 0.52** Cpt1a 1.17 0.90  0.83  0.97 
 
Scd1 0.67*  1.27  0.88 0.84 Pck1 1.68 0.88  0.97  1.40 
Cholesterol Metabolism 
Hmgcs1 0.22**  0.26**  0.36** 0.29* Cyp7a1 0.39** 1.55  0.80  0.42* 
Ldlr 0.47**  0.51**  0.54** 0.43** Cyp27a1 0.75** 0.73**  0.78*  0.71* 
 
Hmgcr 0.49**  0.52**  0.54* 0.29** Abcc2 0.98 1.08  1.17  1.26 
Protein Degradation 
Psme3 0.74*  0.63**  0.65** 0.65** Psmb2 1.03 1.01  0.91  0.96 
Psmd1 0.93  0.74*  0.83 0.84 Psmd14 1.08 0.93  0.88  1.08 
Psmb5 0.92  0.97  0.87 0.84* Psma1 1.14 0.98  1.06  1.26†† 
Dscr2 0.93  0.93  0.91 0.83* Psma5 1.18† 0.99  1.02  1.37† 
Ubc 0.87  1.01  1.02 1.05 Psme1 1.49†† 1.32  1.37††  1.41 
Tnfsf5ip1 0.96  1.03  1.04 0.98 Psma3 1.12† 1.16†  1.01  1.11† 
Psmd2 0.98  0.90  0.85 0.89 Psme2 1.48†† 1.36††  1.49†  1.64† 
 
Psmb1 1.02  0.91  0.87 0.99 
Data are shown as ratio of mean mRNA expression level in mice fed the atherogenic diet to that in 
control mice.  
n = 4 for each time point in both groups. 
Compared with control mice, significantly decreased: *P < 0.05, **P < 0.01; significantly increased: 
†P < 0.05, ††P < 0.01. 
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 Supplemental Materials and Methods 
 
Blood chemistry.  Blood glucose concentration was measured using the 
FreeStyle system (Kissei Pharmaceutical Co., Matsumoto, Japan). Assays for 
serum alanine aminotransferase (ALT) and total cholesterol were performed using 
reagents purchased from Kanto Chemical Co. (Tokyo, Japan) and Sysmex (Kobe, 
Japan), respectively. Serum triglyceride and high-density lipoprotein 
(HDL)-cholesterol concentrations were assayed using commercial kits (Sekisui 
Medical Co., Tokyo, Japan). The serum concentration of derivatives of reactive 
oxygen metabolites (d-ROMs), a marker of oxidative stress, was measured using a 
previously described method [37]. The intra- and interassay coefficients of 
variation were all < 10%. 
DNA chips.  We designed 65mer oligonucleotide DNA probes for 190 mouse 
genes linked to circadian clock, energy production, redox regulation, reactive 
oxygen species (ROS) defense, mitogen-activated protein kinase (MAPK) cascade, 
energy and cholesterol metabolism, and protein degradation using ProbeQuest 
software (Dynacom Co., Mobara, Japan). The sequence of the probe for each gene 
was selected considering melting temperature, specificity, secondary structure, and 
low complexity sequences and was located within 1000 bases from the 3’-end of 
mRNA sequences. Melting temperatures of designed probes were between 70°C 
and 80°C. Synthesized probes were installed onto Genopal (Mitsubishi Rayon Co., 
Tokyo, Japan; Supplemental Fig. 1; http://www.mrc.co.jp/genome/e/index.html), 
which consists of hollow plastic fibers. In this system, oligonucleotide DNA probes 
are immobilized to a hydrophilic gel within the three-dimensional space of each 
 1
 hollow fiber [38, 39]. 
RNA isolation and DNA chip analysis.  Total RNA was extracted from liver 
samples using the RNeasy Mini Kit (Qiagen, Valencia, CA). All total RNA samples 
were analyzed using an Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, 
CA) for quality. Biotinylated antisense RNA was synthesized and amplified from 
total RNA (1 μg) using the MessageAmpII biotin enhanced amplification kit 
(Applied Biosystems, Foster City, CA) according to the manufacturer’s protocol. 
After purification of the aRNA, the biotinylated aRNA (5 μg) was fragmented 
using 10× fragmentation reagents (Applied Biosystems), by heating at 70°C for 
7.5 min. 
    Hybridization was carried out with the DNA chips in 150 μL hybridization 
buffer (0.12 M Tris HCl / 0.12M NaCl / 0.05% Tween-20 and 5 μg fragmented 
biotinylated aRNA) at 65°C overnight. After hybridization, the DNA chips were 
washed twice in 0.12 M Tris HCl / 0.12 M NaCl / 0.05% Tween-20 at 65°C for 
20 min, followed by washing in 0.12 M Tris HCl / 0.12M NaCl for 10 min. Then 
hybridized aRNA was labeled with 2 μg/mL streptavidin-Cy5 (GE Healthcare, 
Little Chalfont, UK) in 0.12 M Tris HCl / 0.12 M NaCl for 30 min at room 
temperature. After fluorescent labeling, the DNA chips were washed four times in 
0.12 M Tris HCl / 0.12 M NaCl / 0.05% Tween-20 at room temperature for 5 min 
each. DNA chips were scanned at multiple exposure times, ranging from 0.1 to 40 s, 
using a DNA chip reader (Yokogawa Electric, Tokyo, Japan) with multi-beam 
excitation technology. The intensity values with the best exposure condition for 
each spot were selected. The median value of background spots was subtracted 
from the intensity value in each gene, and thereafter the value was normalized to 
 2
 the expression of an endogenous control, Arbp (NM_007475.4). 
Real-time quantitative PCR.  cDNA was synthesized from total RNA (1 μg) 
using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). 
Gene expression was analyzed by real-time quantitative PCR using the Applied 
Biosystems 7500 Fast Real-Time PCR system. All specific sets of primers and 
TaqMan probes (TaqMan Gene Expression Assays) were obtained from Applied 
Biosystems. Gene expression levels of the target sequences were normalized to the 
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 Supplemental Figure Legends 
 
Supplemental Figure 1. 
Features of the fibrous DNA Chip Genopal. Genopal (Mitsubishi Rayon Co., 
Tokyo, Japan) is a commercially produced, fibrous DNA chip manufactured with 
the company’s unique hollow fiber block slicing method. 
 
Supplemental Figure 2. 
Correlation between relative expression levels as determined by the DNA chip and 
by real-time PCR. The relative expression value of a liver total RNA sample to a 
mixture of 10-tissue total RNA samples (FirstChoice mouse total RNA, Applied 
Biosystems) was determined for each gene using both methods. Data are expressed 
as log2-transformed values. The correlation was assessed by Pearson’s regression 
analysis. 
 
Supplemental Figure 3. 
Representative liver histology in 10-week-old mice fed a regular or an atherogenic 
diet. The atherogenic diet was given from 5 to 10 weeks of age. Liver sections were 
stained with hematoxylin and eosin. The arrows indicate infiltration of 
inflammatory cells into the hepatic parenchyma. The scale bars represent 25 μm. 
 
Supplemental Figure 4. 
Daily mRNA expression profiles of the circadianly expressed genes related to ROS 
 4
 defense (A) and energy production and redox regulation (B) in the livers of mice 
fed a regular (black circles) or an atherogenic (white circles) diet. Transcript levels 
of the clock genes were determined by the custom-made, high-precision DNA chip. 
Data are means ± SEM of four mice at each time point and are expressed as relative 












y = 1.07x + 0.18
r2 = 0.93
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